Back

Metabolomic and Lipidomic Analysis of Manganese-Associated Parkinsonism: a Case-Control Study in Brescia, Italy

Lewis, F.; Shoieb, D.; Azmoun, S.; Colicino, E.; Jin, Y.; Chi, J.; Gu, H.; Placidi, D.; Padovani, A.; Pilotto, A.; Pepe, F.; Turla, M.; Crippa, P.; Wang, X.; Lucchini, R.

2024-09-06 neurology
10.1101/2024.09.04.24313002 medRxiv
Show abstract

Background and ObjectivesExcessive Manganese (Mn) exposure is neurotoxic and can cause Mn-Induced Parkinsonism (MnIP), marked by cognitive and motor dysfunction. Although metabolomic and lipidomic research in Parkinsonism (PD) patients exists, it remains limited. This study hypothesizes distinct metabolomic and lipidomic profiles based on exposure status, disease diagnosis, and their interaction. MethodsWe used a case-control design with a 2x2 factorial framework to investigate the metabolomic and lipidomic alterations associated with Mn exposure and their link to PD. The study population of 97 individuals was divided into four groups: non-exposed controls (n=23), exposed controls (n=25), non-exposed with PD (n=26) and exposed with PD (n=23). Cases, defined by at least two cardinal PD features (excluding vascular, iatrogenic, and traumatic origins), were recruited from movement disorder clinics in four hospitals in Brescia, Northern Italy. Controls, free from neurological or psychiatric conditions, were selected from the same hospitals. Exposed subjects resided in metallurgic regions (Val Camonica and Bagnolo Mella) for at least 8 continuous years, while non-exposed subjects lived in low-exposure areas around Lake Garda and Brescia city. We conducted untargeted analyses of metabolites and lipids in whole blood samples using ultra-high-performance liquid chromatography (UHPLC) and mass spectrometry (MS), followed by statistical analyses including Principal Component Analysis (PCA), Partial Least Squares-Discriminant Analysis (PLS-DA), and Two-Way Analysis of Covariance (ANCOVA). ResultsMetabolomic analysis revealed modulation of alanine, aspartate, and glutamate metabolism (Impact=0.05, p=0.001) associated with disease effect; butanoate metabolism (Impact=0.03, p=0.004) with the exposure effect; and vitamin B6 metabolism (Impact=0.08, p=0.03) with the interaction effect. Differential relative abundances in 3- sulfoxy-L-Tyrosine ({beta}=1.12, FDR p<0.001), glycocholic acid ({beta}=0.48, FDR p=0.03), and palmitelaidic acid ({beta}=0.30, FDR p<0.001) were linked to disease, exposure, and interaction effects, respectively. In the lipidome, ferroptosis (Pathway Lipids=11, FDR p=0.03) associated with the disease effect and sphingolipid signaling (Pathway Lipids=9, FDR p=0.04) associated with the interaction effect were significantly altered. Lipid classes triacylglycerols, ceramides, and phosphatidylethanolamines showed differential relative abundances associated with disease, exposure, and interaction effects, respectively. DiscussionThese findings suggest that PD and Mn exposure induce unique metabolomic and lipidomic changes, potentially serving as biomarkers for MnIP and warranting further study.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Antioxidants
25 papers in training set
Top 0.1%
27.9%
2
Scientific Reports
3612 papers in training set
Top 9%
7.1%
3
Molecular Neurobiology
53 papers in training set
Top 0.1%
5.8%
4
Neurobiology of Disease
148 papers in training set
Top 1%
2.9%
5
PLOS ONE
5266 papers in training set
Top 42%
2.5%
6
Alzheimer's & Dementia
163 papers in training set
Top 1%
2.2%
7
Molecular Neurodegeneration
55 papers in training set
Top 0.8%
2.2%
50% of probability mass above
8
npj Parkinson's Disease
105 papers in training set
Top 0.8%
2.0%
9
Frontiers in Molecular Biosciences
102 papers in training set
Top 0.6%
1.8%
10
Parkinsonism & Related Disorders
25 papers in training set
Top 0.3%
1.8%
11
Metabolites
53 papers in training set
Top 0.4%
1.8%
12
Metabolomics
14 papers in training set
Top 0.1%
1.5%
13
Free Radical Biology and Medicine
36 papers in training set
Top 0.4%
1.5%
14
Cells
249 papers in training set
Top 3%
1.5%
15
Advanced Science
286 papers in training set
Top 6%
1.2%
16
Frontiers in Neuroscience
256 papers in training set
Top 5%
1.1%
17
Translational Psychiatry
260 papers in training set
Top 3%
1.1%
18
Journal of Alzheimer’s Disease
50 papers in training set
Top 1%
1.0%
19
Journal of Parkinson's Disease
13 papers in training set
Top 0.2%
1.0%
20
Journal of Neurochemistry
53 papers in training set
Top 1%
0.9%
21
Toxicology and Applied Pharmacology
14 papers in training set
Top 0.2%
0.9%
22
Heliyon
152 papers in training set
Top 7%
0.9%
23
Environment International
43 papers in training set
Top 0.7%
0.9%
24
Molecular Psychiatry
282 papers in training set
Top 5%
0.9%
25
Nature Communications
5641 papers in training set
Top 55%
0.9%
26
eBioMedicine
183 papers in training set
Top 7%
0.6%
27
Cell Communication and Signaling
51 papers in training set
Top 2%
0.6%
28
Chemical Research in Toxicology
10 papers in training set
Top 0.3%
0.6%
29
International Journal of Molecular Sciences
494 papers in training set
Top 16%
0.6%
30
Biomolecules
100 papers in training set
Top 3%
0.6%